Fitness to Practise Cases

[ivory-search id="5173" title="FtP cases search form"]

This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.

Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:

  • Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
  • Employers & HR Teams – to learn about professional accountability and compliance.
  • Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.

How to use this case summary database:

  • Search for specific cases using the search box above. You can search by keyword (e.g., "controlled drugs," "dishonesty," "suspension"), by sanction type (suspension, removal, warning) or issue type (dishonesty, prescribing errors, controlled drugs, etc.)
  • Alternatively, scroll down to browse the latest FtP case summaries.

Why it matters:

The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.

Latest FtP case summaries:

Pharmacist Suspended for Inadequate Prescribing Practices of Saxenda via Online Consultations

Date of Decision: October 20, 2025

Allegations: Inappropriate prescribing and dispensing of Saxenda Failure to obtain adequate health information prior to prescribing Overreliance on online questionnaires Failure to consult or access GP medical records Absence of face-to-face consultations in some cases Failure to consider medication misuse and dependence Prescribing against NICE guidance Failure to ensure appropriate risk assessments, SOPs, and audit systems Inadequate ID checks and record keeping Prescribing without adequate indemnity insurance for international patients

Outcome: Suspension, 3 months with review

Read more »

Pharmacist Warned for Remotely Approving Prescriptions via WhatsApp While Pharmacy Operated Unsupervised

Date of Decision: October 16, 2025

Allegations: The registrant acted as the Responsible Pharmacist on six separate dates but was not physically present at the pharmacy. The pharmacy remained operational without a responsible pharmacist on site. Prescription medication was prepared and/or supplied by unqualified staff during the registrant's absence. The registrant reviewed prescriptions via WhatsApp messages and authorized supply using emoji or brief text confirmations. On one occasion, the registrant was absent for approximately eight hours while knowing there was no responsible pharmacist present and did not arrange for closure or cessation of services.

Outcome: Warning

Read more »

Superintendent Pharmacist Warned Over Lapses in Online Pharmacy Governance and Controlled Drug Wholesale Export

Date of Decision: October 14, 2025

Allegations: Failed to manage risks associated with online pharmacy services, particularly regarding medicines liable to abuse, overuse, or misuse. Did not ensure adequate systems or safeguards for medicines requiring ongoing monitoring. Supplied large quantities of medication to North America without confirming legality or having appropriate indemnity insurance. Supplied medication without possessing the required wholesale distribution licence.

Outcome: Warning issued (published on the register for 12 months)

Read more »

Suspended Sentence for NI Superintendent Pharmacist Following Prolonged Unlawful Supply of Controlled Drugs

Date of Decision: October 9, 2025

Allegations: Criminal convictions relating to the unlawful supply and poor record keeping of multiple Schedule 2 controlled drugs (Co-codamol, Fentanyl, Tapentadol, Methylphenidate, Morphine, Oxycodone). Misconduct by failing to ensure the safe and effective supply of prescription-only medicines. Breach of interim conditions by accessing the pharmacy and PMR unsupervised and outside of working hours.

Outcome: Conditions imposed on registration for 18 months

Read more »

Warning Issued for Inadequate Oversight of High-Risk Online Ozempic Prescribing Service by Superintendent Pharmacist

Date of Decision: October 9, 2025

Allegations: Failure to risk assess or audit an online prescribing service involving high-risk medicines Failure to verify prescriber adherence to UK prescribing guidelines Failure to audit online questionnaire-based consultations Failure to confirm whether patients’ GPs were contacted prior to issuing prescriptions

Outcome: Warning issued

Read more »

Pharmacist Issued Warning Over Improper Mezolar Claims for Discontinued Medication

Date of Decision: September 8, 2023

Allegations: Submitted or permitted claims for Mezolar dispensing that did not occur. Lacked effective systems to identify and properly code non-dispensed prescription items. Knew Mezolar was not dispensed but still submitted claims, representing a systemic failure. Failed to stop repeat prescriptions for discontinued controlled drug and lacked documentation of communication with GP. Did not supervise controlled drug prescribing properly and failed to keep records after medication interventions.

Outcome: Warning issued

Read more »

Pharmacist Suspended After Failing to Comply with Conditions Over Controlled Drugs and Dispensing Errors

Date of Decision: April 15, 2019

Allegations: Numerous and serious errors in the handling of Controlled Drugs (CDs) Dispensing errors over a period of several months (August 2016 – February 2017) Inadequate record-keeping Failure to comply with conditions imposed by the GPhC following initial hearing Failure to engage with regulatory process post-conditions order

Outcome: 6-month suspension order with review

Read more »

Pharmacy Technician Consumed 56 Codeine Tablets Daily at Work – GPhC Lifts Suspension After Evidence of Rehabilitation

Date of Decision: February 5, 2019

Allegations: Removed an unknown quantity of codeine tablets from the pharmacy without authority. Removed an unknown quantity of Orlistat tablets without authority. Did not have a valid prescription for either medication. Consumed some or all of the removed medications. Acted dishonestly by knowingly taking medication without permission.

Outcome: Suspension lifted; registrant’s fitness to practise no longer found to be impaired.

Read more »